“We really want to be a strong partner for our blood center customers in helping them deliver their important mission, which is to provide safe blood for patients.”

William ‘Obi’ M. Greenman President and CEO, Cerus.

 

View the video

Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Visit product website

INTERCEPT® Blood System for Platelets and Plasma

Visit US SiteVisit International Site

At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe.

See Mission and Values

Annual Report

Annual Report 2021

Cerus’ Annual Meeting of Stockholders will be held online on Tuesday, June 3, 2025 at 9:00 a.m. Pacific Time.

Latest Press Releases

06/03/2025
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

05/29/2025
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

05/28/2025
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

5/1/2025
Cerus Corporation Announces First Quarter 2025 Financial Results

04/17/2025
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025